Clinical trial
Pentastarch Use in Cardiac Surgery
NCT00182377 · Hamilton Health Sciences Corporation, Other · Unknown status
Key facts
| NCT number | NCT00182377 |
|---|---|
| Title | Pentastarch Use in Cardiac Surgery |
| Official title | A Randomized, Prospective, Blinded Clinical Trial to Evaluate the Efficacy and Safety of Pentastarch Use in Patients Undergoing Coronary Artery Bypass Surgery or Valve Replacement Surgery Using Cardiopulmonary Bypass Circuits |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Cardiac Surgery, Cardiopulmonary Bypass |
| Intervention type | Drug |
| Interventions | Pentastarch (displace either 500 ml or 1000 ml of pump prime with pentastarch) |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 20, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: